These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31460743)

  • 1. Discovery of Arginine Ethyl Ester as Polyglutamine Aggregation Inhibitor: Conformational Transitioning of Huntingtin N-Terminus Augments Aggregation Suppression.
    Singh V; Patel KA; Sharma RK; Patil PR; Joshi AS; Parihar R; Athilingam T; Sinha N; Ganesh S; Sinha P; Roy I; Thakur AK
    ACS Chem Neurosci; 2019 Sep; 10(9):3969-3985. PubMed ID: 31460743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmidazolium Chloride and Its Complex with Serum Albumin Prevent Huntingtin Exon1 Aggregation.
    Singh V; Deepak RNVK; Sengupta B; Joshi AS; Fan H; Sen P; Thakur AK
    Mol Pharm; 2018 Aug; 15(8):3356-3368. PubMed ID: 29979597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nt17 Domain and its Helical Conformation Regulate the Aggregation, Cellular Properties and Neurotoxicity of Mutant Huntingtin Exon 1.
    Vieweg S; Mahul-Mellier AL; Ruggeri FS; Riguet N; DeGuire SM; Chiki A; Cendrowska U; Dietler G; Lashuel HA
    J Mol Biol; 2021 Oct; 433(21):167222. PubMed ID: 34492254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of polyglutamine aggregation by SIMILAR huntingtin N-terminal sequences: Prospective molecules for preclinical evaluation in Huntington's disease.
    Burra G; Thakur AK
    Biopolymers; 2017 Jul; 108(4):. PubMed ID: 28406522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms.
    Pandey NK; Isas JM; Rawat A; Lee RV; Langen J; Pandey P; Langen R
    J Biol Chem; 2018 Feb; 293(7):2597-2605. PubMed ID: 29282287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein phosphatase 1 regulates huntingtin exon 1 aggregation and toxicity.
    Branco-Santos J; Herrera F; Poças GM; Pires-Afonso Y; Giorgini F; Domingos PM; Outeiro TF
    Hum Mol Genet; 2017 Oct; 26(19):3763-3775. PubMed ID: 28934390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural insights into the aggregation mechanism of huntingtin exon 1 protein fragment with different polyQ-lengths.
    Priya SB; Gromiha MM
    J Cell Biochem; 2019 Jun; 120(6):10519-10529. PubMed ID: 30672003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting.
    DeGuire SM; Ruggeri FS; Fares MB; Chiki A; Cendrowska U; Dietler G; Lashuel HA
    J Biol Chem; 2018 Nov; 293(48):18540-18558. PubMed ID: 30185623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract.
    Bravo-Arredondo JM; Kegulian NC; Schmidt T; Pandey NK; Situ AJ; Ulmer TS; Langen R
    J Biol Chem; 2018 Dec; 293(51):19613-19623. PubMed ID: 30315108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Terminal Fragments of Huntingtin Longer than Residue 170 form Visible Aggregates Independently to Polyglutamine Expansion.
    Chen MZ; Mok SA; Ormsby AR; Muchowski PJ; Hatters DM
    J Huntingtons Dis; 2017; 6(1):79-91. PubMed ID: 28339398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation.
    Minakawa EN; Popiel HA; Tada M; Takahashi T; Yamane H; Saitoh Y; Takahashi Y; Ozawa D; Takeda A; Takeuchi T; Okamoto Y; Yamamoto K; Suzuki M; Fujita H; Ito C; Yagihara H; Saito Y; Watase K; Adachi H; Katsuno M; Mochizuki H; Shiraki K; Sobue G; Toda T; Wada K; Onodera O; Nagai Y
    Brain; 2020 Jun; 143(6):1811-1825. PubMed ID: 32436573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Small Molecule Inhibitors of Huntingtin Exon 1 Aggregation by FRET-Based High-Throughput Screening in Living Cells.
    Lo CH; Pandey NK; Lim CK; Ding Z; Tao M; Thomas DD; Langen R; Sachs JN
    ACS Chem Neurosci; 2020 Aug; 11(15):2286-2295. PubMed ID: 32568514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
    Chen M; Wolynes PG
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of neurotoxic HTTex1 assemblies in human neurons.
    Chongtham A; Isas JM; Pandey NK; Rawat A; Yoo JH; Mastro T; Kennedy MB; Langen R; Khoshnan A
    Neurobiol Dis; 2021 Nov; 159():105517. PubMed ID: 34563643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
    van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
    BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological polyQ expansion does not alter the conformation of the Huntingtin-HAP40 complex.
    Huang B; Guo Q; Niedermeier ML; Cheng J; Engler T; Maurer M; Pautsch A; Baumeister W; Stengel F; Kochanek S; Fernández-Busnadiego R
    Structure; 2021 Aug; 29(8):804-809.e5. PubMed ID: 33909994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A huntingtin peptide inhibits polyQ-huntingtin associated defects.
    Arribat Y; Bonneaud N; Talmat-Amar Y; Layalle S; Parmentier ML; Maschat F
    PLoS One; 2013; 8(7):e68775. PubMed ID: 23861941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyglutamine-Specific Gold Nanoparticle Complex Alleviates Mutant Huntingtin-Induced Toxicity.
    Wahyuningtyas D; Chen WH; He RY; Huang YA; Tsao CK; He YJ; Yu CY; Lu PC; Chen YC; Wang SH; Ng KC; Po-Wen Chen B; Wei PK; Shie JJ; Kuo CH; Sun YH; Jen-Tse Huang J
    ACS Appl Mater Interfaces; 2021 Dec; 13(51):60894-60906. PubMed ID: 34914364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational dynamics and self-association of intrinsically disordered Huntingtin exon 1 in cells.
    Büning S; Sharma A; Vachharajani S; Newcombe E; Ormsby A; Gao M; Gnutt D; Vöpel T; Hatters DM; Ebbinghaus S
    Phys Chem Chem Phys; 2017 May; 19(17):10738-10747. PubMed ID: 28094373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of Q-length selectivity for the MW1 antibody-huntingtin interaction.
    Bravo-Arredondo JM; Venkataraman R; Varkey J; Isas JM; Situ AJ; Xu H; Chen J; Ulmer TS; Langen R
    J Biol Chem; 2023 Apr; 299(4):104616. PubMed ID: 36931390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.